Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T17:08:10.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The Publications section was updated to state that publications are provided voluntarily by the study entrants and are automatically filled from PubMed, and the revision version changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:51:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Notice about government funding and NIH/CC operating status has been removed from the page.
    Difference
    0.2%
    Check dated 2025-11-17T15:00:05.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The update shows minor textual edits and a timestamp change, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:32:28.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    1%
    Check dated 2025-10-05T10:39:53.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    The page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.
    Difference
    0.2%
    Check dated 2025-09-28T03:23:33.000Z thumbnail image

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.